Literature DB >> 21705218

Synthesis and evaluation of 1-cyclopropyl-2-thioalkyl-8-methoxy fluoroquinolones.

Kevin R Marks1, Muhammad Malik, Arkady Mustaev, Hiroshi Hiasa, Karl Drlica, Robert J Kerns.   

Abstract

Novel fluoroquinolone derivatives substituted with a 2-thioalkyl moiety, with and without a concomitant 3-carboxylate group, were synthesized to evaluate the effect of C-2 thioalkyl substituents on gyrase binding and inhibition. The presence of a 2-thioalkyl group universally decreased activity as compared to parent fluoroquinolones. However, with derivatives of moxifloxacin the presence of either a 2-thioalkyl group or a 3-carboxylate moiety increased activity over the 2,3-unsubstituted derivative. Energy minimization of structures provides an explanation for relative activities of fluoroquinolones having a C-2 thio moiety.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705218      PMCID: PMC3138821          DOI: 10.1016/j.bmcl.2011.05.112

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  33 in total

1.  3-hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists.

Authors:  Vittoria Colotta; Daniela Catarzi; Flavia Varano; Francesca Romana Calabri; Guido Filacchioni; Chiara Costagli; Alessandro Galli
Journal:  Bioorg Med Chem Lett       Date:  2004-05-03       Impact factor: 2.823

2.  Synthesis and antibacterial activity of novel 7-substituted-6-fluoro-1- fluoromethyl-4-oxo-4H-[1,3thiazeto[3,2-a]quinoline-3-carboxylic acid derivatives.

Authors:  M Matsuoka; J Segawa; I Amimoto; Y Masui; Y Tomii; M Kitano; M Kise
Journal:  Chem Pharm Bull (Tokyo)       Date:  1999-12       Impact factor: 1.645

Review 3.  The quinolones: decades of development and use.

Authors:  A M Emmerson; A M Jones
Journal:  J Antimicrob Chemother       Date:  2003-05       Impact factor: 5.790

4.  Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance.

Authors:  Alexandre Wohlkonig; Pan F Chan; Andrew P Fosberry; Paul Homes; Jianzhong Huang; Michael Kranz; Vaughan R Leydon; Timothy J Miles; Neil D Pearson; Rajika L Perera; Anthony J Shillings; Michael N Gwynn; Benjamin D Bax
Journal:  Nat Struct Mol Biol       Date:  2010-08-29       Impact factor: 15.369

Review 5.  Fluoroquinolones: action and resistance.

Authors:  Karl Drlica; Muhammad Malik
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

6.  Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3- carboxylic acids.

Authors:  J Segawa; M Kitano; K Kazuno; M Matsuoka; I Shirahase; M Ozaki; M Matsuda; Y Tomii; M Kise
Journal:  J Med Chem       Date:  1992-12-11       Impact factor: 7.446

7.  Studies on pyridonecarboxylic acids. III. Synthesis and antibacterial activity evaluation of 1,8-disubstituted 6-fluoro-4-oxo-7-piperazinyl-4H-[1,3]thiazeto[3,2- a]quinoline-3-carboxylic acid derivatives.

Authors:  J Segawa; K Kazuno; M Matsuoka; I Shirahase; M Ozaki; M Matsuda; Y Tomii; M Kitano; M Kise
Journal:  Chem Pharm Bull (Tokyo)       Date:  1995-01       Impact factor: 1.645

Review 8.  Structure-activity and structure-side-effect relationships for the quinolone antibacterials.

Authors:  J M Domagala
Journal:  J Antimicrob Chemother       Date:  1994-04       Impact factor: 5.790

9.  Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae.

Authors:  Katherine A Gould; Xiao-Su Pan; Robert J Kerns; L Mark Fisher
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Synthesis and antibacterial activity of new tetracyclic quinolone antibacterials.

Authors:  M Taguchi; H Kondo; Y Inoue; Y Kawahata; Y Jinbo; F Sakamoto; G Tsukamoto
Journal:  J Med Chem       Date:  1992-01       Impact factor: 7.446

View more
  1 in total

1.  The C7-aminomethylpyrrolidine group rescues the activity of a thio-fluoroquinolone.

Authors:  Sarah R C Lentz; Pratik R Chheda; Lisa M Oppegard; Tyrell R Towle; Robert J Kerns; Hiroshi Hiasa
Journal:  Biochimie       Date:  2019-02-11       Impact factor: 4.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.